308 related articles for article (PubMed ID: 10353846)
1. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.
Stamps SL; Fitzgerald MC; Whitman CP
Biochemistry; 1998 Jul; 37(28):10195-202. PubMed ID: 9665726
[TBL] [Abstract][Full Text] [Related]
4. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Swope M; Sun HW; Blake PR; Lolis E
EMBO J; 1998 Jul; 17(13):3534-41. PubMed ID: 9649424
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoate.
Golubkov PA; Johnson WH; Czerwinski RM; Person MD; Wang SC; Whitman CP; Hackert ML
Bioorg Chem; 2006 Aug; 34(4):183-99. PubMed ID: 16780921
[TBL] [Abstract][Full Text] [Related]
8. The roles of active-site residues in the catalytic mechanism of trans-3-chloroacrylic acid dehalogenase: a kinetic, NMR, and mutational analysis.
Azurmendi HF; Wang SC; Massiah MA; Poelarends GJ; Whitman CP; Mildvan AS
Biochemistry; 2004 Apr; 43(14):4082-91. PubMed ID: 15065850
[TBL] [Abstract][Full Text] [Related]
9. Internal dynamics and ionization states of the macrophage migration inhibitory factor: comparison between wild-type and mutant forms.
Soares TA; Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2002 Nov; 65(4):313-23. PubMed ID: 12382291
[TBL] [Abstract][Full Text] [Related]
10. Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism.
Soares T; Goodsell D; Ferreira R; Olson AJ; Briggs JM
J Mol Recognit; 2000; 13(3):146-56. PubMed ID: 10867710
[TBL] [Abstract][Full Text] [Related]
11. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase.
Rosengren E; Aman P; Thelin S; Hansson C; Ahlfors S; Björk P; Jacobsson L; Rorsman H
FEBS Lett; 1997 Nov; 417(1):85-8. PubMed ID: 9395080
[TBL] [Abstract][Full Text] [Related]
12. Phenylpyruvate tautomerase activity of trans-3-chloroacrylic acid dehalogenase: evidence for an enol intermediate in the dehalogenase reaction?
Poelarends GJ; Johnson WH; Serrano H; Whitman CP
Biochemistry; 2007 Aug; 46(33):9596-604. PubMed ID: 17661448
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants.
Stamps SL; Taylor AB; Wang SC; Hackert ML; Whitman CP
Biochemistry; 2000 Aug; 39(32):9671-8. PubMed ID: 10933783
[TBL] [Abstract][Full Text] [Related]
14. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
15. Kinetic and structural effects of mutations of the catalytic amino-terminal proline in 4-oxalocrotonate tautomerase.
Czerwinski RM; Johnson WH; Whitman CP
Biochemistry; 1997 Nov; 36(47):14551-60. PubMed ID: 9398173
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of a macrophage migration inhibitory factor homologue from the marine cyanobacterium Prochlorococcus marinus .
Wasiel AA; Rozeboom HJ; Hauke D; Baas BJ; Zandvoort E; Quax WJ; Thunnissen AM; Poelarends GJ
Biochemistry; 2010 Sep; 49(35):7572-81. PubMed ID: 20715791
[TBL] [Abstract][Full Text] [Related]
17. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
[TBL] [Abstract][Full Text] [Related]
18. Detection of Plasmodium falciparum derived macrophage migration inhibitory factor homologue in the sera of malaria patients.
Shao D; Han Z; Lin Y; Zhang L; Zhong X; Feng M; Guo Y; Wang H
Acta Trop; 2008 Apr; 106(1):9-15. PubMed ID: 18262164
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis.
Tan TH; Edgerton SA; Kumari R; McAlister MS; Roe SM; Nagl S; Pearl LH; Selkirk ME; Bianco AE; Totty NF; Engwerda C; Gray CA; Meyer DJ
Biochem J; 2001 Jul; 357(Pt 2):373-83. PubMed ID: 11439086
[TBL] [Abstract][Full Text] [Related]
20. A kinetic and stereochemical investigation of the role of lysine-32 in the phenylpyruvate tautomerase activity catalyzed by macrophage migration inhibitory factor.
Johnson WH; Czerwinski RM; Stamps SL; Whitman CP
Biochemistry; 1999 Nov; 38(48):16024-33. PubMed ID: 10625471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
